PGEN Randal J Kirk sells $15.8M worth of shares
Apr 01, 2026, 4:35 PM
0.00%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
Randal J Kirk sold 4,772,781 shares of PGEN on 30 March at $3.30 per share, worth a total of $15.8M. They now own 80,672,818 PGEN shares, or a 94% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.